Verified Nov 2026
Batteries & E-Mobility
·

Incheon
·
Since 2011
Samsung Biologics is a contract development and manufacturing organization (CDMO) for biopharmaceuticals, headquartered in Incheon, South Korea, and founded in 2011. Part of the Samsung Group, the company employs over 5,000 people and operates single-site CDMO facility with 604,000 liters of production capacity. It serves major pharmaceutical and biotech clients globally with end-to-end services from cell line development through aseptic filling and holds ISO 9001 certification.
Samsung Biologics at a glance
Revenue
$1-5B
Est. band
Employees
5,000-10,000
Founded
2011
Headquarters
Incheon
Certifications
ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
15 years in operation (founded 2011).
Holds ISO 9001 certification(s) per public sources.
Overview
Samsung Biologics is a contract development and manufacturing organization (CDMO) for biopharmaceuticals, headquartered in Incheon, South Korea, and founded in 2011. Part of the Samsung Group, the company employs over 5,000 people and operates single-site CDMO facility with 604,000 liters of production capacity. It serves major pharmaceutical and biotech clients globally with end-to-end services from cell line development through aseptic filling and holds ISO 9001 certification.
At a glance
Attribute | Detail |
|---|---|
Founded | 2011 |
Headquarters | Incheon |
Employees | 5,000-10,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 9001 |
What Samsung Biologics makes
The company provides cell line development, process optimization, large-scale cell cultivation, aseptic filling, and quality assurance services across the full biopharmaceutical product lifecycle.
Certifications
Samsung Biologics is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — samsungbiologics.com
Latest developments
2026-11-11 — Samsung Biologics' 2.7 trillion won capital increase subscription rate nears 100%… “Polypeptide acquisition on track” - MoneyToday (mt.co.kr)
2026-09-10 — Samsung Biologics wins $262m contract, expands Songdo site (bioprocessintl.com)
2026-09-10 — Samsung Biologics Wins 350.8 Billion Won CMO Deal With European Drugmaker - Seoul Economic Daily (sedaily.com)
2026-08-31 — SAMSUNG BIOLOGICS Launches Tender Offer to Acquire Polypeptide Group… Up to 2.7 Trillion Won - EDAILY (edaily.co.kr)
2026-08-28 — Samsung Biologics Announces KRW 3 Trillion Rights Offering to Fund Its Next-Phase Expansion | Samsung Biologics (samsungbiologics.com)
2026-07-20 — Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India | Morningstar (morningstar.com)
Facilities
Samsung Biologics is headquartered in Incheon. Public sources also reference these locations:
Rockville, Maryland — samsungbiologics.com
Songdo, South Korea — bioprocessintl.com
Company details
Samsung Biologics operates facilities in Incheon, South Korea and Rockville, Maryland, serving a diverse global client base of major pharmaceutical companies and biotech innovators across Europe and the United States. Samsung Biologics was founded in 2011, has an estimated 5,000-10,000 employees, and is headquartered in Incheon. On the LightSource stability read it is rated "Established & active": 15 years in operation (founded 2011). Holds ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Samsung Biologics make?
Samsung Biologics is a contract development and manufacturing organization (CDMO) for biopharmaceuticals, headquartered in Incheon, South Korea, and founded in 2011. Part of the Samsung Group, the company employs over 5,000 people and operates single-site CDMO facility with 604,000 liters of production capacity. It serves major pharmaceutical and biotech clients globally with end-to-end services from cell line development through aseptic filling and holds ISO 9001 certification.
Where is Samsung Biologics headquartered?
Samsung Biologics is headquartered in Incheon.
When was Samsung Biologics founded?
Samsung Biologics was founded in 2011.
How big is Samsung Biologics?
Samsung Biologics has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Samsung Biologics hold?
Samsung Biologics lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
